Chemotherapy Given Near the End of Life by Community Oncologists for Advanced Non-Small Cell Lung Cancer

Abstract

The availability of new chemotherapeutic agents has caused a subsequent increase in the length of time patients are receiving chemotherapy with advanced NSCLC. This would suggest an increased use of chemotherapy near the end of life, which was identified in this study.